Biomarkers are used as tools in cancer diagnostics and in treatment stratification. In most
cancers, there are increased levels of one or several members of the matrix …

Breast cancer (BC) is the most occurring cancer in females and the second most commonly
occurring cancer world-wide. Early detection of BC may ease the treatment and prevent the …

Although mangiferin which is a naturally occurring glucosylxanthone has exhibited
promising anticancer activities, the detailed molecular mechanism of mangiferin on cancers …

Small interfering RNA (siRNA) has significant potential to evolve into a new class of
pharmaceutical inhibitors, but technologies that enable robust, tissue‐specific intracellular …

Only two genome-wide association studies (GWAS) have been conducted to date to identify
potential markers for total mortality after diagnosis of breast cancer. Here, we report the …

Breast cancer (BRCA) is the most common cancer in the world, of which incidence rate and
mortality are the highest in women. Being responsible for the remodeling and degradation of …

The prognostic role of matrix metalloproteinase-7 in gastric cancer survival has been widely
evaluated. However, the results are controversial. We aimed to set up a meta-analysis to …

Introduction Previous studies have identified common germline variants nominally
associated with breast cancer survival. These associations have not been widely replicated …

The matrix metalloproteinases (MMP) can degrade various components of the extracellular
matrix and its functional genetic polymorphisms may be associated with breast cancer risk …

With the recent advancement of technologies, it is progressively easier to collect diverse
types of genome-wide data. It is commonly expected that by analyzing these data in an …